Diabetic Angiopathies Terminated Phase 2 / 3 Trials for Bemiparin (DB09258)

IndicationStatusPhase
DBCOND0031847 (Diabetic Angiopathies)Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00399425Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic PatientsTreatment